Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ENANTA PHARMACEUTICALS INC | d814941dex312.htm |
| EX-31.1 - EX-31.1 - ENANTA PHARMACEUTICALS INC | d814941dex311.htm |
| EX-10.5 - EX-10.5 - ENANTA PHARMACEUTICALS INC | d814941dex105.htm |
| EX-32.1 - EX-32.1 - ENANTA PHARMACEUTICALS INC | d814941dex321.htm |
| EX-21.1 - EX-21.1 - ENANTA PHARMACEUTICALS INC | d814941dex211.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ENANTA PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - ENANTA PHARMACEUTICALS INC | d814941d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-189217 and No. 333-192935) of Enanta Pharmaceuticals, Inc. of our report dated December 11, 2014 relating to the financial statements, which appears in this Form 10-K.
| /s/ PricewaterhouseCoopers LLP |
| Boston, Massachusetts |
| December 11, 2014 |